Join advocates, life sciences companies, patients, researchers, investors and regulators at the Rare Disease Innovation & Partnering Summit to tackle challenges in furthering therapeutic and curative progress and ensuring patient access.
The DIA 2020 Global Annual Meeting will bring together patients, industry, regulators, and academia from all angles of the product lifecycle, from more than 50 countries.
Bringing together a global gathering of 1,500 leaders in orphan drugs from 50 countries, World Orphan Drug Congress USA will feature over 260 presentations covering all aspects of orphan drug development and rare disease research.
Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL.
A vendor might be able to perform home health visits, but a collaborator can help create a faster, more comprehensive study with fewer risks.
A delayed database build creates ripples throughout the rest of the clinical trial, setting up sites and sponsors for significant delays overall. Use these steps to ensure you get a quality clinical trial database build.
There is no one definition of a patient-centric clinical trial that has resulted in a whole lot of buzz — and cynicism — within the pharma industry. There are, however, essentially 4 elements that all patient-centric clinical trials have in common. Find out what tangible steps sponsors can take to achieve patient centricity within their drug development process—no matter what technology or methodology they use.
Firma’s ISO 9001 recertification indicates that we meet or exceed the international standard that specifies a Quality Management System (QMS) and consistently provide services that meet our client’s regulations and requirements.
Firma Clinical Research, a niche service provider to the pharmaceutical and medical device industry, recently promoted Jennifer Mintz to Vice President of Sales and Marketing. In her new role, Mintz is responsible for leading Firma’s business development organization and marketing strategy, working closely with all departments to help achieve the [...]
Firma Clinical Research and The Myositis Association Join Forces to Enhance Clinical Trial Patient Care Partner Training
Firma Clinical Research, a niche service provider, is partnering with The Myositis Association (TMA) on a multi-faceted project to better integrate the experience of patients into the training of clinical trial investigators and support providers.
Patient-centric clinical trials are easier said than done. In an Applied Clinical Trials article, Michael Keens, COO, Firma Clinical, offers Sponsors, CROs and Sites the four key elements that can ensure a patient-centric clinical trial. Read the article HERE.
There are 5 critical areas where sponsors can make a significant impact on the burden of clinical trial participation for patients. And, that, at the end of the day, is true patient-centricity.
Michael Keens, COO, and Lisa Gorman, VP, of Operations, discuss trends in patient centricity.
Firma Clinical is exhibiting at this year's Alzheimer's Association International Conference in Los Angeles, California.
Firma Clinical Research's eBook explains how to recruit, engage and retain more patients to improve clinical trials.
Firma Clinical is exhibiting at this year's DIA Global Annual Meeting. Schedule a time to meet with us.
Firma team members will be at Booth #1949 to discuss the company’s unique approach to patient-centric clinical trials.
Firma Clinical is hosting an educational breakfast to bring in sponsors, as well as individuals, from patient advocacy groups.
Firma’s Michael Keens and Darcy Forman to Speak at MAGI’s Clinical Research Conference – 2019 East Program
Firma’s Michael Keens and Darcy Forman will speak at MAGI’s Clinical Research Conference - 2019 East on May 6.
PharmaVOICE Features Firma Clinical Research Executives Darcy Forman and Michael Keens’ Thoughts on Patient Engagement
Firma Clinical Research leadership figures, Darcy Forman and Michael Keens, were featured in the April 2019 edition of PharmaVOICE. Forman and Keens share information and perspective on patient-focused advancements in wearables, patient engagement liaisons and integrating patient input to reduce burden of treatment. Read the full article here.